GlassScriptPhysician profile
Sandra S Sallee
NPI 1053413526
$2,900.41
in general payments reported to CMS, 2019-2025
25 companies · $617 in 2025
The $617 reported for 2025 was more than what 77% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $477 · 2022: $477 · 2023: $708 · 2024: $621 · 2025: $617.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,786 · Education: $160.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,786.30 |
| Education | $159.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $471.71 | 2022-2024 | Veozah |
| Abbvie INC. | $435.53 | 2021-2023 | |
| Mayne Pharma Commercial LLC | $427.82 | 2021-2025 | |
| Avion Pharmaceuticals | $219.85 | 2022 | |
| Aspira Women'S Health INC | $159.94 | 2021-2025 | Ova1 |
| Bayer Healthcare Pharmaceuticals INC. | $153.88 | 2023 | |
| Acella Pharmaceuticals, LLC | $130.01 | 2023 | NP Thyroid 60 |
| Coopersurgical, INC. | $119.88 | 2022-2025 | Paragard T 380a |
| Organon LLC | $114.21 | 2021-2024 | Nexplanon |
| Sumitomo Pharma America, INC. | $93.70 | 2023-2025 | Myfembree |
| Myovant Sciences INC. | $79.21 | 2021-2022 | |
| Viiv Healthcare Company | $73.94 | 2025 | Apretude |
| Pfizer INC. | $62.00 | 2023-2024 | |
| Evofem Biosciences, INC. | $56.19 | 2021-2025 | Phexxi, Solosec, Phexx |
| Ethicon US, LLC | $46.23 | 2023 | Surgicel Nu-Knit |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Millicent US INC | $42.22 | 2025 | Femlyv, Femring, Intrarosa |
| Exact Sciences Corporation | $39.18 | 2025 | Cologuard Collection Kit |
| Hologic Sales and Service, LLC | $33.78 | 2022-2025 | Fetal Fibronectin Enzyme Immunoassay |
| Shield Therapeutics INC | $29.53 | 2025 | |
| Conmed Corporation | $23.33 | 2025 | Airseal |
| Biogen, INC. | $19.98 | 2025 | Zurzuvae |
| Exeltis, USA INC. | $18.18 | 2023 | Slynd |
| Abbott Laboratories | $18.06 | 2025 | Alinity M |
| Therapeuticsmd, INC. | $16.79 | 2021 | |
| Merck Sharp & Dohme LLC | $15.26 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandra Sallee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.